Correlation Between Si Bone and Cytek Biosciences
Can any of the company-specific risk be diversified away by investing in both Si Bone and Cytek Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Si Bone and Cytek Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Si Bone and Cytek Biosciences, you can compare the effects of market volatilities on Si Bone and Cytek Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Si Bone with a short position of Cytek Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Si Bone and Cytek Biosciences.
Diversification Opportunities for Si Bone and Cytek Biosciences
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between SIBN and Cytek is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Si Bone and Cytek Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytek Biosciences and Si Bone is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Si Bone are associated (or correlated) with Cytek Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytek Biosciences has no effect on the direction of Si Bone i.e., Si Bone and Cytek Biosciences go up and down completely randomly.
Pair Corralation between Si Bone and Cytek Biosciences
Given the investment horizon of 90 days Si Bone is expected to generate 0.64 times more return on investment than Cytek Biosciences. However, Si Bone is 1.56 times less risky than Cytek Biosciences. It trades about 0.12 of its potential returns per unit of risk. Cytek Biosciences is currently generating about -0.02 per unit of risk. If you would invest 1,441 in Si Bone on April 25, 2025 and sell it today you would earn a total of 335.00 from holding Si Bone or generate 23.25% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Si Bone vs. Cytek Biosciences
Performance |
Timeline |
Si Bone |
Cytek Biosciences |
Si Bone and Cytek Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Si Bone and Cytek Biosciences
The main advantage of trading using opposite Si Bone and Cytek Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Si Bone position performs unexpectedly, Cytek Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytek Biosciences will offset losses from the drop in Cytek Biosciences' long position.Si Bone vs. Orthofix Medical | Si Bone vs. Orthopediatrics Corp | Si Bone vs. Rxsight | Si Bone vs. Sight Sciences |
Cytek Biosciences vs. MaxCyte | Cytek Biosciences vs. Sight Sciences | Cytek Biosciences vs. CVRx Inc | Cytek Biosciences vs. Neuropace |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |